NO20030295L - Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser - Google Patents

Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser

Info

Publication number: NO20030295L
Authority: NO; Norway
Prior art keywords: valproic acid; manners; derivatives; treatment; bipolar disorders
Prior art date: 2000-07-21

Application number

NO20030295A

Other languages

English (en)

Norwegian (no)

Other versions

NO20030295D0 (no

Inventor

Mitchell Shirvan

Meir Bialer

Original Assignee

Yissum Res Dev Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2003-01-20

Publication date

2003-01-20

2003-01-20 Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co

2003-01-20 Publication of NO20030295D0 publication Critical patent/NO20030295D0/no

2003-01-20 Publication of NO20030295L publication Critical patent/NO20030295L/no

Links

208000020925 Bipolar disease Diseases 0.000 title 1
NIJJYAXOARWZEE-UHFFFAOYSA-N Valproic acid Chemical class CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 title 1
229960000604 valproic acid Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20030295A 2000-07-21 2003-01-20 Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser NO20030295L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22010200P	2000-07-21	2000-07-21
PCT/US2001/023116 WO2002007677A2 (en)	2000-07-21	2001-07-20	Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder

Publications (2)

Publication Number	Publication Date
NO20030295D0 NO20030295D0 (no)	2003-01-20
NO20030295L true NO20030295L (no)	2003-01-20

Family

ID=22822065

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030295A NO20030295L (no)	2000-07-21	2003-01-20	Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser

Country Status (16)

Country	Link
US (2)	US6555585B2 (cs)
EP (1)	EP1303289A4 (cs)
JP (1)	JP2004520263A (cs)
KR (1)	KR100843703B1 (cs)
CN (1)	CN1251758C (cs)
AU (1)	AU2001280699A1 (cs)
CA (1)	CA2416821A1 (cs)
CZ (1)	CZ2004266A3 (cs)
HU (1)	HUP0600526A2 (cs)
IL (1)	IL153942A0 (cs)
MX (1)	MXPA03000547A (cs)
NO (1)	NO20030295L (cs)
NZ (1)	NZ523917A (cs)
PL (1)	PL365588A1 (cs)
WO (1)	WO2002007677A2 (cs)
ZA (1)	ZA200300641B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL365588A1 (en) *	2000-07-21	2005-01-10	Teva Pharmaceutical Industries, Ltd.	Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
US20060223888A1 (en) *	2002-12-16	2006-10-05	Abbott Frank S	Valproic acid analogues and pharmaceutical composition thereof
US20040176463A1 (en) *	2003-02-05	2004-09-09	Daniella Licht	Immediate release formulation of n-(2-propylpentanoyl)glycinamide
EP1626707A4 (en) *	2003-02-05	2009-07-01	Yissum Res Dev Co	CONTINUOUSLY RELEASE FORMULA OF N- (2-PROPYLPENTANOYL) GLYCINAMIDE, AND ASSOCIATED COMPOUNDS
IL157751A0 (en) *	2003-02-28	2004-03-28	Yissum Res Dev Co	New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
IL156203A0 (en) *	2003-05-29	2003-12-23	Yissum Res Dev Co	Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
EP1491188A1 (en) *	2003-06-25	2004-12-29	G2M Cancer Drugs AG	Topical use of valproic acid for the prevention or treatment of skin disorders
US20060004098A1 (en)	2003-07-28	2006-01-05	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Compounds useful for treating neurological disorders
EP1713486A4 (en) *	2003-12-02	2009-04-29	Sheldon Leslie James	COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2006012603A2 (en) *	2004-07-22	2006-02-02	Nps Pharmaceuticals, Inc.	Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases
WO2007028030A2 (en) *	2005-09-02	2007-03-08	Picobella, Llc	Oncogenic regulatory rnas for diagnostics and therapeutics
US7459280B2 (en) *	2006-02-27	2008-12-02	Picobella, Llc	Methods for diagnosing and treating kidney cancer
US20080267977A1 (en) *	2007-04-26	2008-10-30	Friedrich-Alexander University Of Erlangen-Nuremberg	Combined immunological agent and sensitizing agent for the treatment of cancer
CA2936158C (en)	2014-02-05	2023-06-13	Yeda Research And Development Co. Ltd.	Use of mir-135 or precursor thereof for the treatment and diagnosis of a bipolar disease
KR102635938B1 (ko) *	2016-12-14	2024-02-13	에스케이바이오팜 주식회사	양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
IL282188A (en)	2021-04-08	2022-11-01	Yeda Res & Dev	Combined use of ketamine and bretigabine for the treatment of psychiatric disorders

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU988188A3 (ru)	1973-12-14	1983-01-07	Эсакмадьяросаги Ведьимювек (Инопредприятие)	Способ получени N,N-дизамещенных амидов карбоновых кислот
DE3010599A1 (de)	1979-03-22	1980-10-09	Continental Pharma	Derivate von glycinamid, deren herstellung und verwendung
US4301176A (en) *	1980-08-18	1981-11-17	Warner-Lambert Company	Method of administering calcium valproate
FR2489319A1 (fr)	1980-08-27	1982-03-05	Clin Midy	Derives de l'acide amino-4 butyrique et les medicaments, actifs notamment sur le systeme nerveux central, en contenant
BE885303A (fr)	1980-09-19	1981-03-19	Continental Pharma	Glycinamides
LU83729A1 (fr) *	1981-11-04	1983-09-01	Galephar	Sels d'acide valproique,leur preparation et leur utilisation
DK373383A (da)	1982-08-20	1984-02-21	Midit	Fremgangsmaade til fremstilling af omega-aminosyrederivater
US4913906B1 (en)	1985-02-28	2000-06-06	Yissum Res Dev Co	Controlled release dosage form of valproic acid
IT1190133B (it)	1986-06-19	1988-02-10	Chiesi Farma Spa	Derivati di acido valproico e di acido (e)-2-valproenoico,procedimento per la loro preparazione e relative composizioni farmaceutiche
ATE88631T1 (de)	1986-09-17	1993-05-15	Clintec Nutrition Co	Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
US5169642A (en) *	1988-06-24	1992-12-08	Abbott Laboratories	Sustained-release drug dosage units
US6287598B1 (en) *	1993-05-28	2001-09-11	Alza Corporation	Method for providing sustained antiepileptic therapy
US5585358A (en)	1993-07-06	1996-12-17	Yissum Research Development Corporation Of The Hebrew University Of Jerusalem	Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
UA48219C2 (uk)	1996-03-25	2002-08-15	Елі Ліллі Енд Компані	Композиція для вгамування болю (варіанти) та спосіб вгамування болю
IL121268A0 (en)	1997-07-09	1998-01-04	Dpharm Ltd	Branched chain fatty acids their derivatives and use in the treatment of central nervous system disorders
BR9911421A (pt)	1998-06-22	2001-03-27	American Biogenetic Sciences	Uso de análogo do ácido valpróico para o tratamento e prevenção da enxaqueca e doenças emocionais
PL365588A1 (en) *	2000-07-21	2005-01-10	Teva Pharmaceutical Industries, Ltd.	Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder

2001
- 2001-07-20 PL PL01365588A patent/PL365588A1/xx not_active Application Discontinuation
- 2001-07-20 AU AU2001280699A patent/AU2001280699A1/en not_active Abandoned
- 2001-07-20 US US09/910,543 patent/US6555585B2/en not_active Expired - Fee Related
- 2001-07-20 IL IL15394201A patent/IL153942A0/xx not_active IP Right Cessation
- 2001-07-20 KR KR1020037000586A patent/KR100843703B1/ko not_active Expired - Fee Related
- 2001-07-20 WO PCT/US2001/023116 patent/WO2002007677A2/en not_active Ceased
- 2001-07-20 MX MXPA03000547A patent/MXPA03000547A/es active IP Right Grant
- 2001-07-20 CZ CZ2004266A patent/CZ2004266A3/cs unknown
- 2001-07-20 EP EP01959110A patent/EP1303289A4/en not_active Withdrawn
- 2001-07-20 JP JP2002513415A patent/JP2004520263A/ja active Pending
- 2001-07-20 CA CA002416821A patent/CA2416821A1/en not_active Abandoned
- 2001-07-20 CN CNB018139663A patent/CN1251758C/zh not_active Expired - Fee Related
- 2001-07-20 HU HU0600526A patent/HUP0600526A2/hu unknown
- 2001-07-20 NZ NZ523917A patent/NZ523917A/en unknown
2003
- 2003-01-20 NO NO20030295A patent/NO20030295L/no not_active Application Discontinuation
- 2003-01-23 ZA ZA200300641A patent/ZA200300641B/en unknown
- 2003-04-28 US US10/425,375 patent/US20030212142A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2004520263A (ja)	2004-07-08
PL365588A1 (en)	2005-01-10
MXPA03000547A (es)	2004-04-05
NZ523917A (en)	2004-11-26
AU2001280699A1 (en)	2002-02-05
US20020103237A1 (en)	2002-08-01
NO20030295D0 (no)	2003-01-20
CN1251758C (zh)	2006-04-19
CN1446097A (zh)	2003-10-01
CA2416821A1 (en)	2002-01-31
KR20030036610A (ko)	2003-05-09
KR100843703B1 (ko)	2008-07-04
WO2002007677A2 (en)	2002-01-31
US6555585B2 (en)	2003-04-29
CZ2004266A3 (cs)	2005-02-16
ZA200300641B (en)	2004-01-26
WO2002007677A3 (en)	2002-05-30
IL153942A0 (en)	2003-07-31
EP1303289A4 (en)	2009-08-05
US20030212142A1 (en)	2003-11-13
HUP0600526A2 (en)	2006-11-28
EP1303289A2 (en)	2003-04-23

Legal Events

Date	Code	Title	Description
2010-03-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DE60023128D1 (de)	2006-02-23	Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
NO20030295L (no)	2003-01-20	Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser
NO20001754D0 (no)	2000-04-05	Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
PL361849A1 (en)	2004-10-04	Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
NO20022585D0 (no)	2002-05-31	Pyrrolidinacetamidderivat alene eller i kombinasjon for behandling av CNS-forstyrrelser
AU9287401A (en)	2002-04-08	Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
HUP0104425A3 (en)	2003-05-28	Anthranilic acid amides and the use thereof for the treatment of angiogenesis
EP1465854A4 (en)	2005-06-08	CHALCON DERIVATIVES AND THEIR USE FOR THE TREATMENT OF DISEASES
NO20041588L (no)	2004-04-19	Anvendelse av flibanserin ved behandling av seksuelle forstyrrelser
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
EE04854B1 (et)	2007-06-15	Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks
NO20031903L (no)	2003-06-25	Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser
EP1531824A4 (en)	2005-09-21	CYCLOTHIOCARBAMATE DERIVATIVES AS PR-MODULATORS AND THEIR USE IN THE TREATMENT OF SKIN DISEASES
PL356784A1 (pl)	2004-07-12	Substancja do zastosowania w leczeniu łuszczycy
NO20024924D0 (no)	2002-10-11	Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner
NO20001412D0 (no)	2000-03-17	Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
NO20032340L (no)	2003-07-21	Substituerte aminofuran-2-yl-eddiksyre- og aminotien-2-yl- eddiksyrederivater og deres anvendelse for behandling av migrene og henholdsvissmerte
DE60017133D1 (de)	2005-02-03	Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
NO20006506D0 (no)	2000-12-20	Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer
AU2002220735A1 (en)	2002-08-15	Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
ITMI20010957A0 (it)	2001-05-10	Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche
EP1330271A4 (en)	2005-11-09	USE OF TRANSCRIPTION FACTORS IN THE TREATMENT OF INFLAMMATION AND OTHER DISEASES
GB0007217D0 (en)	2000-05-17	Materials and methods relating to the treatment of leukaemias
EE200100527A (et)	2002-12-16	Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
EP1150669A4 (en)	2005-06-22	FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF